8-chloro-2,3-benzodiazepine derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C540S567000

Reexamination Certificate

active

07960375

ABSTRACT:
The invention relates to new 8-chloro-2,3-benzodiazepine derivatives of the general formula (I), wherein R stands for a lower alkyl group or a group of the general formula —NH—R′, wherein R′ stands for a lower alkyl or a lower cycloalkyl group), and pharmaceutically acceptable acid addition salts thereof. The invention also encompasses a process for the preparation of said compounds, pharmaceutical compositions containing them and new intermediates useful for the preparation of the new 8-chloro-2,3-benzodiazepine derivatives. The compounds according to the invention possess AMPA/kainate receptor inhibiting activity.

REFERENCES:
patent: 4322346 (1982-03-01), Korosi et al.
patent: 4614740 (1986-09-01), Lang et al.
patent: 4840948 (1989-06-01), Lang et al.
patent: 6200970 (2001-03-01), Ling et al.
patent: 2566774 (1986-01-01), None
patent: WO 9211262 (1992-07-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

8-chloro-2,3-benzodiazepine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 8-chloro-2,3-benzodiazepine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 8-chloro-2,3-benzodiazepine derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2639784

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.